Britain MPs complain about Tamiflu; Teva releases generic Detrol; Pain pandemic blamed on opioid restrictions;

@FiercePharma: Rakesh Bamzai Joins Mylan as President, India Commercial and Emerging Markets. Release | Follow @FiercePharma

@EricPFierce: Merck is cutting 150 in its Saphris sales team after selling the drug to Forest for $240M. More | Follow @EricPFierce

@CarlyHFierce: Cue more drama in Teva's boardroom as its CEO announcement nears. Yesterday's story | Follow @CarlyHFierce

> Members of Britain's Parliament continue to expresss displeasure over how much the goverment has spent on Roche's Tamiflu, given the questions over its effectiveness. Story

> Johnson & Johnson's ($JNJ) newest plant in China will be its first in the western part of the country. Report

> Teva Pharmaceutical Industries ($TEVA) has launched an authorized generic of Pfizer's ($PFE) incontinence drug Detrol. Release

> Boehringer Ingelheim is buying more real estate in Columbus, OH. Report

> Spanish blood products group Grifols has gotten a $1.5 billion bridge loan to assist with its buyout of the blood transfusion testing unit of Novartis ($NVS). Item

Medical Device News

@FierceMedDev: The CFO of troubled Mela Sciences resigned on Dec. 31. CEO Rose Crane is filling in. Release | Follow @FierceMedDev

@MichaelGFierce: Gene therapy technique from Washington University in St. Louis targets tumor blood vessels. Article | Follow @MichaelGFierce

@GalenMoore: Drug companies accused of holding back complete information on clinical trials. Story | Follow @GalenMoore

> Nipro is recalling glucose meters over a display mixup. More

> Quidel entices investors with FDA thumbs-up for strep test. News

> Boston Scientific looks to follow up on a big 2013. Report

Biotech News

@FierceBiotech: Marina Biotech, Mirna Therapeutics amend license deal to develop microRNA-based therapeutics. Release | Follow @FierceBiotech

@JohnCFierce: Top FierceBiotech story yesterday: Is it human, animal or plant? At Bayer, they're mixing all three in new R&D recipe. More | Follow @JohnCFierce

@DamianFierce: The long, strange trip that was Wright Medical's 2013. Report | Follow @DamianFierce

@EmilyMFierce: Cancer Research UK to repurpose an AstraZeneca asthma drug for kidney cancer. Story from FierceBiotech Research | Follow @EmilyMFierce

> Ambitious HDL program joins a growing list of high-profile clinical failures. Story

> A step ahead of controversial transparency rules, Sanofi commits to open access. Report

> NeXeption raises $21.5M to launch dermatology startup Alexar. Article

And Finally... A new report on opioid pain drugs faults many developing countries for restricting their use to stop abuse, saying it is causing a global pain pandemic. Story

Suggested Articles

Amid Amgen's pricing war with Sanofi and Regeneron's Praluent, PCSK9 cholesterol fighter Repatha has shown a clinical benefit for HIV patients.

A month after the FDA approved it, Esperion's Nexletol showed it can lower cholesterol regardless of statin and ezitimibe treatment.

AstraZeneca's Farxiga can help prevent worsening or death in heart failure patients regardless of other therapies received, according to new data.